Global Cancer Drugs Sales Market Report 2021

1 Cancer Drugs Market Overview

• 1.1 Cancer Drugs Product Scope
• 1.2 Cancer Drugs Segment by Type
  • 1.2.1 Global Cancer Drugs Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Chemotherapy
  • 1.2.3 Targeted Therapy
  • 1.2.4 Immunotherapy
  • 1.2.5 Hormonal Therapy (Biologic Therapy)
  • 1.2.6 Others
• 1.3 Cancer Drugs Segment by Application
  • 1.3.1 Global Cancer Drugs Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Blood Cancer
  • 1.3.3 Breast Cancer
  • 1.3.4 Gastrointestinal Cancer
  • 1.3.5 Prostate Cancer
  • 1.3.6 Respiratory/Lung Cancer
  • 1.3.7 Other Cancers
• 1.4 Cancer Drugs Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Cancer Drugs Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Cancer Drugs Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Cancer Drugs Price Trends (2016-2027)

2 Cancer Drugs Estimates and Forecasts by Region

• 2.1 Global Cancer Drugs Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Cancer Drugs Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Cancer Drugs Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Cancer Drugs Revenue Market Share by Region (2016-2021)
• 2.3 Global Cancer Drugs Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Cancer Drugs Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Cancer Drugs Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Cancer Drugs Estimates and Projections (2016-2027)
  • 2.4.2 Europe Cancer Drugs Estimates and Projections (2016-2027)
  • 2.4.3 China Cancer Drugs Estimates and Projections (2016-2027)
  • 2.4.4 Japan Cancer Drugs Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Cancer Drugs Estimates and Projections (2016-2027)
  • 2.4.6 India Cancer Drugs Estimates and Projections (2016-2027)

3 Global Cancer Drugs Competition Landscape by Players

• 3.1 Global Top Cancer Drugs Players by Sales (2016-2021)
• 3.2 Global Top Cancer Drugs Players by Revenue (2016-2021)
• 3.3 Global Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Drugs as of 2020)
• 3.4 Global Cancer Drugs Average Price by Company (2016-2021)
• 3.5 Manufacturers Cancer Drugs Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Cancer Drugs Market Size by Type

• 4.1 Global Cancer Drugs Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Cancer Drugs Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Cancer Drugs Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Cancer Drugs Price by Type (2016-2021)
• 4.2 Global Cancer Drugs Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Cancer Drugs Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Cancer Drugs Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Cancer Drugs Price Forecast by Type (2022-2027)

5 Global Cancer Drugs Market Size by Application

• 5.1 Global Cancer Drugs Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Cancer Drugs Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Cancer Drugs Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Cancer Drugs Price by Application (2016-2021)
• 5.2 Global Cancer Drugs Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Cancer Drugs Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Cancer Drugs Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Cancer Drugs Price Forecast by Application (2022-2027)

6 North America Cancer Drugs Market Facts & Figures

• 6.1 North America Cancer Drugs Sales by Company
  • 6.1.1 North America Cancer Drugs Sales by Company (2016-2021)
  • 6.1.2 North America Cancer Drugs Revenue by Company (2016-2021)
• 6.2 North America Cancer Drugs Sales Breakdown by Type
  • 6.2.1 North America Cancer Drugs Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Cancer Drugs Sales Breakdown by Type (2022-2027)
• 6.3 North America Cancer Drugs Sales Breakdown by Application
  • 6.3.1 North America Cancer Drugs Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Cancer Drugs Sales Breakdown by Application (2022-2027)

7 Europe Cancer Drugs Market Facts & Figures

• 7.1 Europe Cancer Drugs Sales by Company
  • 7.1.1 Europe Cancer Drugs Sales by Company (2016-2021)
  • 7.1.2 Europe Cancer Drugs Revenue by Company (2016-2021)
• 7.2 Europe Cancer Drugs Sales Breakdown by Type
  • 7.2.1 Europe Cancer Drugs Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Cancer Drugs Sales Breakdown by Type (2022-2027)
• 7.3 Europe Cancer Drugs Sales Breakdown by Application
  • 7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)

8 China Cancer Drugs Market Facts & Figures

• 8.1 China Cancer Drugs Sales by Company
  • 8.1.1 China Cancer Drugs Sales by Company (2016-2021)
  • 8.1.2 China Cancer Drugs Revenue by Company (2016-2021)
• 8.2 China Cancer Drugs Sales Breakdown by Type
  • 8.2.1 China Cancer Drugs Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Cancer Drugs Sales Breakdown by Type (2022-2027)
• 8.3 China Cancer Drugs Sales Breakdown by Application
  • 8.3.1 China 175 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 175 Sales Breakdown by Application (2022-2027)

9 Japan Cancer Drugs Market Facts & Figures

• 9.1 Japan Cancer Drugs Sales by Company
  • 9.1.1 Japan Cancer Drugs Sales by Company (2016-2021)
  • 9.1.2 Japan Cancer Drugs Revenue by Company (2016-2021)
• 9.2 Japan Cancer Drugs Sales Breakdown by Type
  • 9.2.1 Japan Cancer Drugs Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Cancer Drugs Sales Breakdown by Type (2022-2027)
• 9.3 Japan Cancer Drugs Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Cancer Drugs Market Facts & Figures

• 10.1 Southeast Asia Cancer Drugs Sales by Company
  • 10.1.1 Southeast Asia Cancer Drugs Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Cancer Drugs Revenue by Company (2016-2021)
• 10.2 Southeast Asia Cancer Drugs Sales Breakdown by Type
  • 10.2.1 Southeast Asia Cancer Drugs Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Cancer Drugs Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Cancer Drugs Sales Breakdown by Application
  • 10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)

11 India Cancer Drugs Market Facts & Figures

• 11.1 India Cancer Drugs Sales by Company
  • 11.1.1 India Cancer Drugs Sales by Company (2016-2021)
  • 11.1.2 India Cancer Drugs Revenue by Company (2016-2021)
• 11.2 India Cancer Drugs Sales Breakdown by Type
  • 11.2.1 India Cancer Drugs Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Cancer Drugs Sales Breakdown by Type (2022-2027)
• 11.3 India Cancer Drugs Sales Breakdown by Application
  • 11.3.1 India Cancer Drugs Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Cancer Drugs Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Cancer Drugs Business

• 12.1 Roche
  • 12.1.1 Roche Corporation Information
  • 12.1.2 Roche Business Overview
  • 12.1.3 Roche Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Roche Cancer Drugs Products Offered
  • 12.1.5 Roche Recent Development
• 12.2 Novartis
  • 12.2.1 Novartis Corporation Information
  • 12.2.2 Novartis Business Overview
  • 12.2.3 Novartis Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Novartis Cancer Drugs Products Offered
  • 12.2.5 Novartis Recent Development
• 12.3 Celgene
  • 12.3.1 Celgene Corporation Information
  • 12.3.2 Celgene Business Overview
  • 12.3.3 Celgene Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Celgene Cancer Drugs Products Offered
  • 12.3.5 Celgene Recent Development
• 12.4 Bristol-Myers Squibb
  • 12.4.1 Bristol-Myers Squibb Corporation Information
  • 12.4.2 Bristol-Myers Squibb Business Overview
  • 12.4.3 Bristol-Myers Squibb Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Bristol-Myers Squibb Cancer Drugs Products Offered
  • 12.4.5 Bristol-Myers Squibb Recent Development
• 12.5 Amgen
  • 12.5.1 Amgen Corporation Information
  • 12.5.2 Amgen Business Overview
  • 12.5.3 Amgen Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Amgen Cancer Drugs Products Offered
  • 12.5.5 Amgen Recent Development
• 12.6 Johnson & Johnson
  • 12.6.1 Johnson & Johnson Corporation Information
  • 12.6.2 Johnson & Johnson Business Overview
  • 12.6.3 Johnson & Johnson Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Johnson & Johnson Cancer Drugs Products Offered
  • 12.6.5 Johnson & Johnson Recent Development
• 12.7 Pfizer
  • 12.7.1 Pfizer Corporation Information
  • 12.7.2 Pfizer Business Overview
  • 12.7.3 Pfizer Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Pfizer Cancer Drugs Products Offered
  • 12.7.5 Pfizer Recent Development
• 12.8 Takeda
  • 12.8.1 Takeda Corporation Information
  • 12.8.2 Takeda Business Overview
  • 12.8.3 Takeda Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Takeda Cancer Drugs Products Offered
  • 12.8.5 Takeda Recent Development
• 12.9 Eli Lilly
  • 12.9.1 Eli Lilly Corporation Information
  • 12.9.2 Eli Lilly Business Overview
  • 12.9.3 Eli Lilly Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Eli Lilly Cancer Drugs Products Offered
  • 12.9.5 Eli Lilly Recent Development
• 12.10 AstraZeneca
  • 12.10.1 AstraZeneca Corporation Information
  • 12.10.2 AstraZeneca Business Overview
  • 12.10.3 AstraZeneca Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 AstraZeneca Cancer Drugs Products Offered
  • 12.10.5 AstraZeneca Recent Development
• 12.11 Astellas
  • 12.11.1 Astellas Corporation Information
  • 12.11.2 Astellas Business Overview
  • 12.11.3 Astellas Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.11.4 Astellas Cancer Drugs Products Offered
  • 12.11.5 Astellas Recent Development
• 12.12 Merck & Co.
  • 12.12.1 Merck & Co. Corporation Information
  • 12.12.2 Merck & Co. Business Overview
  • 12.12.3 Merck & Co. Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.12.4 Merck & Co. Cancer Drugs Products Offered
  • 12.12.5 Merck & Co. Recent Development
• 12.13 Sanofi
  • 12.13.1 Sanofi Corporation Information
  • 12.13.2 Sanofi Business Overview
  • 12.13.3 Sanofi Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.13.4 Sanofi Cancer Drugs Products Offered
  • 12.13.5 Sanofi Recent Development
• 12.14 Bayer
  • 12.14.1 Bayer Corporation Information
  • 12.14.2 Bayer Business Overview
  • 12.14.3 Bayer Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.14.4 Bayer Cancer Drugs Products Offered
  • 12.14.5 Bayer Recent Development
• 12.15 Biogen Idec
  • 12.15.1 Biogen Idec Corporation Information
  • 12.15.2 Biogen Idec Business Overview
  • 12.15.3 Biogen Idec Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.15.4 Biogen Idec Cancer Drugs Products Offered
  • 12.15.5 Biogen Idec Recent Development
• 12.16 Eisai
  • 12.16.1 Eisai Corporation Information
  • 12.16.2 Eisai Business Overview
  • 12.16.3 Eisai Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.16.4 Eisai Cancer Drugs Products Offered
  • 12.16.5 Eisai Recent Development
• 12.17 Teva
  • 12.17.1 Teva Corporation Information
  • 12.17.2 Teva Business Overview
  • 12.17.3 Teva Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.17.4 Teva Cancer Drugs Products Offered
  • 12.17.5 Teva Recent Development
• 12.18 Otsuka
  • 12.18.1 Otsuka Corporation Information
  • 12.18.2 Otsuka Business Overview
  • 12.18.3 Otsuka Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.18.4 Otsuka Cancer Drugs Products Offered
  • 12.18.5 Otsuka Recent Development
• 12.19 Merck KGaA
  • 12.19.1 Merck KGaA Corporation Information
  • 12.19.2 Merck KGaA Business Overview
  • 12.19.3 Merck KGaA Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.19.4 Merck KGaA Cancer Drugs Products Offered
  • 12.19.5 Merck KGaA Recent Development
• 12.20 Ipsen
  • 12.20.1 Ipsen Corporation Information
  • 12.20.2 Ipsen Business Overview
  • 12.20.3 Ipsen Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.20.4 Ipsen Cancer Drugs Products Offered
  • 12.20.5 Ipsen Recent Development
• 12.21 AbbVie
  • 12.21.1 AbbVie Corporation Information
  • 12.21.2 AbbVie Business Overview
  • 12.21.3 AbbVie Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.21.4 AbbVie Cancer Drugs Products Offered
  • 12.21.5 AbbVie Recent Development
• 12.22 Gilead Sciences
  • 12.22.1 Gilead Sciences Corporation Information
  • 12.22.2 Gilead Sciences Business Overview
  • 12.22.3 Gilead Sciences Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.22.4 Gilead Sciences Cancer Drugs Products Offered
  • 12.22.5 Gilead Sciences Recent Development

13 Cancer Drugs Manufacturing Cost Analysis

• 13.1 Cancer Drugs Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Cancer Drugs
• 13.4 Cancer Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Cancer Drugs Distributors List
• 14.3 Cancer Drugs Customers

15 Market Dynamics

• 15.1 Cancer Drugs Market Trends
• 15.2 Cancer Drugs Drivers
• 15.3 Cancer Drugs Market Challenges
• 15.4 Cancer Drugs Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List